Skip to main content
. 2022 Aug 5;9:1632–1638. doi: 10.1016/j.toxrep.2022.07.018

Fig. 3.

Fig. 3

Karyotyping analysis of primary fibroblasts treated with Peptide 14. Representative karyotype analysis of human dermal fibroblasts (31 y) control (A) and 10 days treated with 1 μM Peptide 14 (B). As depicted, 19 out of 20 metaphases analyzed showed normal karyotype. Peptide 14 was therefore considered safe.